Precise treatments for schizophrenia: where is the way forward?
作者信息
Zhang Chen, Mao Yemeng, Song Lisheng
机构信息
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
出版信息
Gen Psychiatr. 2018 Aug 29;31(1):e000002. doi: 10.1136/gpsych-2018-000002. eCollection 2018.
Abstract
摘要
相似文献
1
Precise treatments for schizophrenia: where is the way forward?
Gen Psychiatr. 2018 Aug 29;31(1):e000002. doi: 10.1136/gpsych-2018-000002. eCollection 2018.
2
Forward and backward visual masking in schizophrenia: influence of age.
Psychol Med. 2003 Jul;33(5):887-95. doi: 10.1017/s003329170200716x.
3
The experience and consequences of people with mental health problems, the impact of stigma upon people with schizophrenia: a way forward.
J Psychiatr Ment Health Nurs. 2010 Apr;17(3):242-50. doi: 10.1111/j.1365-2850.2009.01506.x.
4
Toward convergence in the medication treatment of bipolar disorder and schizophrenia.
Harv Rev Psychiatry. 2005 Jan-Feb;13(1):28-42. doi: 10.1080/10673220590923164.
5
Belief systems of the general public concerning the appropriate treatments for mental disorders.
Soc Psychiatry Psychiatr Epidemiol. 1997 Nov;32(8):468-73. doi: 10.1007/BF00789141.
6
[3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia.
Neurochem Int. 1997 Jun;30(6):565-74. doi: 10.1016/s0197-0186(96)00124-6.
7
New facts on schizophrenia.
Nurs Times. 1995;91(25):32-3.
8
Frontal/executive impairments in schizophrenia.
Schizophr Bull. 1996;22(1):125-37. doi: 10.1093/schbul/22.1.125.
9
The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group.
Arch Gen Psychiatry. 1997 Jun;54(6):567-72. doi: 10.1001/archpsyc.1997.01830180085011.
10
[Dynamic paradigm in psychopathology: "chaos theory", from physics to psychiatry].
Encephale. 2001 May-Jun;27(3):260-8.
引用本文的文献
1
An in-depth exploration of the association between olanzapine, quetiapine and acute pancreatitis based on real-world datasets and network toxicology analysis.
Front Pharmacol. 2025 May 2;16:1529416. doi: 10.3389/fphar.2025.1529416. eCollection 2025.
2
Treatment of antipsychotic-induced hyperprolactinemia: an umbrella review of systematic reviews and meta-analyses.
Front Psychiatry. 2024 Mar 5;15:1337274. doi: 10.3389/fpsyt.2024.1337274. eCollection 2024.
3
Risk factors of hyperprolactinemia induced by risperidone and olanzapine and their correlations with plasma glucose and lipids.
Gen Psychiatr. 2020 Jul 6;33(4):e100206. doi: 10.1136/gpsych-2020-100206. eCollection 2020.
4
Rare case report of Van Gogh syndrome in a patient with paranoid schizophrenia.
Gen Psychiatr. 2020 Jan 22;33(1):e100095. doi: 10.1136/gpsych-2019-100095. eCollection 2020.
本文引用的文献
1
Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
Psychoneuroendocrinology. 2017 Jul;81:138-143. doi: 10.1016/j.psyneuen.2017.04.014. Epub 2017 Apr 27.
2
Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
J Clin Psychiatry. 2016 Nov;77(11):e1460-e1466. doi: 10.4088/JCP.15m10047.
3
Information Needs in the Precision Medicine Era: How Genetics Home Reference Can Help.
Interact J Med Res. 2016 Apr 27;5(2):e13. doi: 10.2196/ijmr.5199.
4
Complement 3 and metabolic syndrome induced by clozapine: a cross-sectional study and retrospective cohort analysis.
Pharmacogenomics J. 2017 Jan;17(1):92-97. doi: 10.1038/tpj.2015.68. Epub 2015 Oct 27.
5
Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample.
Pharmacogenomics J. 2016 Aug;16(4):352-6. doi: 10.1038/tpj.2015.59. Epub 2015 Sep 1.
6
Pharmacogenetics and outcome with antipsychotic drugs.
Dialogues Clin Neurosci. 2014 Dec;16(4):555-66. doi: 10.31887/DCNS.2014.16.4/jpouget.
7
Pharmacogenetics of antipsychotic treatment in schizophrenia.
Methods Mol Biol. 2014;1175:557-87. doi: 10.1007/978-1-4939-0956-8_14.
8
Pharmacogenetics of antipsychotics.
Can J Psychiatry. 2014 Feb;59(2):76-88. doi: 10.1177/070674371405900203.
9
Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype.
Psychopharmacology (Berl). 2014 May;231(10):2211-8. doi: 10.1007/s00213-013-3410-4. Epub 2014 Jan 22.
10
Association study of Val66Met polymorphism in brain-derived neurotrophic factor gene with clozapine-induced metabolic syndrome: preliminary results.
PLoS One. 2013 Aug 13;8(8):e72652. doi: 10.1371/journal.pone.0072652. eCollection 2013.
Zotero 插件